By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Johannes Vermeerplain 9-1

Amsterdam      The Netherlands
Phone: 31-20-6645500 Fax: n/a



Company News
New Study Published In Lancet Respiratory Medicine Highlights QIAGEN N.V. (QGEN)'s Quantiferon-TB Potential To Predict Active Tuberculosis Risk In Infants 2/16/2017 8:22:59 AM
QIAGEN N.V. (QGEN) Reports Results For Fourth Quarter And Full-Year 2016 2/6/2017 8:53:23 AM
QIAGEN N.V. (QGEN) Hereditary And Rare Disease Solution Chosen By Genomics England 1/31/2017 10:12:58 AM
QIAGEN N.V. (QGEN)'s QuantiFERON-TB Test Wins Tender For Testing Of Republic Of Korea Armed Forces Recruits 1/27/2017 7:47:35 AM
QIAGEN N.V. (QGEN) Announces Adjustment Of Conversion Ratio Under Its 0.375% Senior Unsecured Convertible Notes Due 2019 (ISIN XS1046477235) 1/26/2017 11:30:38 AM
QIAGEN N.V. (QGEN) Release: Diagnostic Company Announces Details For Completion Of Approximately $250 Million Synthetic Share Repurchase 1/19/2017 10:53:25 AM
Better Buy: Opko Health (OPK) vs. QIAGEN N.V. (QGEN) 1/19/2017 6:13:11 AM
QIAGEN N.V. (QGEN) Release: Company To Report Fourth Quarter And Full Year Of 2016 Results 1/18/2017 12:03:23 PM
QIAGEN N.V. (QGEN) Release: Company Announces Comprehensive Range Of Enhancements For GeneReader NGS System 1/10/2017 11:49:18 AM
Singulex Release: Diagnostic Company Enters Into Collaboration With QIAGEN N.V. (QGEN) To Develop Companion Diagnostics 1/10/2017 7:54:59 AM